XML 18 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Net cash flows from operating activities:      
Net income $ 10,778,000 $ 4,005,000 $ 7,322,000
Adjustments to reconcile net income to net cash from operating activities:      
Gain from sale of business components (7,915,000)    
Gain on sale of Medafor investment   (891,000) (530,000)
Depreciation and amortization 8,384,000 5,863,000 6,028,000
Non-cash compensation 6,328,000 5,089,000 3,436,000
Write-down of inventories and deferred preservation costs 1,364,000 1,341,000 680,000
Deferred income taxes 595,000 3,681,000 178,000
Other non-cash adjustments to income 268,000 268,000 (474,000)
Changes in operating assets and liabilities:      
Receivables 4,142,000 (3,809,000) (4,556,000)
Inventories and deferred preservation costs (9,460,000) (2,262,000) (1,131,000)
Prepaid expenses and other assets 515,000 (1,187,000) (2,771,000)
Accounts payable, accrued expenses, and other liabilities 4,720,000 (656,000) (64,000)
Net cash flows provided by operating activities 19,719,000 11,442,000 8,118,000
Net cash flows from investing activities:      
Acquisition of PhotoFix technology (1,226,000)    
Acquisition of French distribution business   1,349,000  
Capital expenditures (6,198,000) (3,490,000) (4,310,000)
Proceeds from sale of business components 19,795,000    
Proceeds from sale of Medafor investment   891,000 530,000
Decrease in restricted cash 5,000,000    
Sales and maturities of restricted securities and investments 1,067,000 1,157,000 639,000
Purchases of restricted securities and investments (1,014,000) (1,085,000) (1,208,000)
Other (126,000) (610,000) (1,004,000)
Net cash flows used in investing activities (73,854,000) (4,486,000) (5,353,000)
Net cash flows from financing activities:      
Proceeds from issuance of term loan 75,000,000    
Repayment of term loan (1,406,000)    
Payment of debt issuance costs (2,289,000)    
Proceeds from exercise of stock options and issuance of common stock 2,203,000 1,526,000 2,675,000
Cash dividends paid   (3,408,000) (3,295,000)
Repurchases of common stock     (5,588,000)
Redemption and repurchase of stock to cover tax withholdings (697,000) (1,386,000) (1,483,000)
Other 617,000 458,000 738,000
Net cash flows provided by (used in) financing activities 73,428,000 (2,810,000) (6,953,000)
Effect of exchange rate changes on cash (239,000) 67,000 (80,000)
Increase (decrease) in cash and cash equivalents 19,054,000 4,213,000 (4,268,000)
Cash and cash equivalents, beginning of year 37,588,000 33,375,000 37,643,000
Cash and cash equivalents, end of year 56,642,000 $ 37,588,000 $ 33,375,000
On-X [Member]      
Net cash flows from investing activities:      
Acquisition of business, net of cash acquired $ (91,152,000)